Biomarker ID 2117 |
| Detailed information | |
|---|---|
| CancerLivER ID | 2117 |
| Biomarker | RNase A |
| Biomarker Name/Symbol (given in Publication) | RNase A |
| Biomolecule | Protein |
| Subject | Human |
| Degree of Validity | RNase as a potential biomarker; but not validated on independent dataset |
| Experimental Condition | Cancer v/s Normal |
| Cancer type | Human(multiple cancer) |
| Regulation | Downregulated in gastric cancer, liver cancer, pancreatic cancer, esophageal cancer, ovary cancer, cervical cancer, bladder cancer, kidney cancer and lung cancer |
| Level of significance | p < 0.01 |
| Source | Serum |
| PMID | 24805924 |
| Type of Biomarker | Diagnostic |
| Pathway | NA |
| Cohort | 303 cancer patients were subjected to comparison with 128 healthy controls |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | Human(multiple cancer) |
| Year of Publication | 2014 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |